This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.
Latest papers
Challenging the Macrocycle Paradigm: Four-Arm, High-Denticity Acyclic Chelators for Radiopharmaceuticals Incorporating Actinium and Lanthanides.
Inorganic chemistry · 2026
In vitro evaluation of anti-HIV radioimmunoconjugates labeled with astatine-211, thorium-227 and actinium-225.
Nuclear medicine and biology · 2026
Evaluating a triaza-18-crown-6 picolinate chelator for [212/203Pb]Pb2+ and [212/213Bi]Bi3+ theranostics.
Dalton transactions (Cambridge, England : 2003) · 2025 · senior author
Latest funding
- $150,000
High Resolution ESI Mass Spectrometer
NSERC · 2018 · Co-investigator
- $726,000
Coordination Chemistry of (Radio)metal Ions
NSERC · 2018 · Principal investigator
- $359,446
Theranostic Vectors to Treat Cancer with Radiometals
NSERC · 2016 · Principal investigator
119 publications.
Challenging the Macrocycle Paradigm: Four-Arm, High-Denticity Acyclic Chelators for Radiopharmaceuticals Incorporating Actinium and Lanthanides.
Fernández-Pavón D, de Blas A, Martínez-Cabanas M, Barriada JL, Patrick BO, Orvig C, Bénard F, Yang H, Wharton L, Jaraquemada-Peláez MG, Rodríguez-Blas T
In vitro evaluation of anti-HIV radioimmunoconjugates labeled with astatine-211, thorium-227 and actinium-225.
Kuhlmann AS, Hamlin DK, Li Y, Wang X, Li L, Orvig C, Kiem HP, Sandmaier BM, Wilbur DS, Pincus S, Harrington RD
Evaluating a triaza-18-crown-6 picolinate chelator for [212/203Pb]Pb2+ and [212/213Bi]Bi3+ theranostics.
Fiaccabrino D, Masvikeni T, McNeil BL, Patrick BO, Jaraquemada-Peláez MG, Schaffer P, Orvig C
H3trica: Versatile Macrocyclic Chelator for [225Ac]Ac3+ and [155/161Tb]Tb3+ Theranostics.
Fiaccabrino D, Masvikeni T, Jaraquemada-Peláez MG, Orvig C, Schaffer P
Toward 68Ga and 64Cu Positron Emission Tomography Probes: Is H2dedpa-N,N'-pram the Missing Link for dedpa Conjugation?
Pena-Bonhome C, Fiaccabrino D, Rama T, Fernández-Pavón D, Southcott L, Zhang Z, Lin KS, de Blas A, Patrick BO, Schaffer P, Orvig C, Jaraquemada-Peláez MG, Rodríguez-Blas T
Rearmed Bifunctional Chelating Ligand for 225Ac/155Tb Precision-Guided Theranostic Radiopharmaceuticals─H4noneunpaX.
Wharton L, Yang H, Jaraquemada-Peláez MG, Merkens H, Engudar G, Ingham A, Koniar H, Radchenko V, Kunz P, Schaffer P, Bénard F, Orvig C
Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with 119Sb.
Kostelnik TI, Olson AP, Grundmane A, Ellison PA, Mynerich J, Chen S, Marinova A, Randhawa P, Karaivanov D, Aluicio-Sarduy E, Barnhart TE, Orvig C, Ramogida CF, Hoehr C, Filosofov D, Engle JW, Radchenko V
H3TPAN-Triazole-Bn-NH2: Tripicolinate Clicked-Bifunctional Chelate for [225Ac]/[111In] Theranostics.
Wharton L, Zhang C, Zeisler J, Rodríguez-Rodríguez C, Osooly M, Radchenko V, Yang H, Lin KS, Bénard F, Schaffer P, Orvig C
H4picoopa─Robust Chelate for 225Ac/111In Theranostics.
Wharton L, Jaraquemada-Peláez MG, Zhang C, Zeisler J, Rodríguez-Rodríguez C, Osooly M, Radchenko V, Yang H, Lin KS, Bénard F, Schaffer P, Orvig C
Trastuzumab-conjugated oxine-based ligand for [89Zr]Zr4+ immunoPET.
Southcott L, Wharton L, Rousseau J, Merkens H, Yang H, Bénard F, Orvig C
High Resolution ESI Mass Spectrometer
Principal investigators: Ryan, Katherine
Coordination Chemistry of (Radio)metal Ions
Principal investigators: Orvig, Chris
Theranostic Vectors to Treat Cancer with Radiometals
Principal investigators: Orvig, Chris
Upgrade to UBC-Chemistry Departmental NMR Facility
Principal investigators: Gates, Derek
ISOSIM - ISOtopes for Science and Medicine
Principal investigators: Kruecken, Reiner
Medicinal Inorganic Chemistry
Principal investigators: Orvig, Chris
Development and potential mechanisms in bifunctional lanthanide compound enhancement of deteriorating bone structures
Principal investigators: Orvig, Chris
Microwave reactor
Principal investigators: Orvig, Chris
Enabling Technologies for Metallic Radioisotopes in Nuclear Medicine
Principal investigators: Adam, Michael
Medicinal inorganic chemistry
Principal investigators: Orvig, Chris
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Paul Schaffer and Valery Radchenko: 28 shared papers
- Paul Schaffer and Chris Orvig: 17 shared papers
- Valery Radchenko and Hua Yang: 17 shared papers
- Valery Radchenko and Chris Orvig: 17 shared papers
- Kuo-Shyan Lin and Paul Schaffer: 14 shared papers
- Paul Schaffer and Hua Yang: 13 shared papers
- Kuo-Shyan Lin and Chris Orvig: 11 shared papers
- Kuo-Shyan Lin and Valery Radchenko: 7 shared papers
- Hua Yang and Chris Orvig: 6 shared papers
- James Johnston and Chris Orvig: 1 shared paper
- Chemistry
- Molecular Oncology
- Mechanical Engineering
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.